Viewing Study NCT02267603

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:38 PM
Ignite Modification Date: 2026-02-20 @ 6:05 PM
Study NCT ID: NCT02267603
Status: COMPLETED
Last Update Posted: 2023-07-05
First Post: 2014-10-14
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Pembrolizumab in Treating Patients With Advanced Merkel Cell Cancer
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Merkel Cell Carcinoma View
None Stage III Merkel Cell Carcinoma AJCC v7 View
None Stage IIIA Merkel Cell Carcinoma AJCC v7 View
None Stage IIIB Merkel Cell Carcinoma AJCC v7 View
None Stage IV Merkel Cell Carcinoma AJCC v7 View
Keywords: